Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells
Clinical trial NCT03242603 · UNKNOWN
Trial details
- NCT number
- NCT03242603
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2019-08-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.